Litigation Details for AbbVie Inc. v. Alvotech hf. (N.D. Ill. 2021)
✉ Email this page to a colleague
AbbVie Inc. v. Alvotech hf. (N.D. Ill. 2021)
| Docket | ⤷ Sign Up | Date Filed | 2021-05-28 |
| Court | District Court, N.D. Illinois | Date Terminated | 2022-03-09 |
| Cause | 35:271 Patent Infringement | Assigned To | John Zihun Lee |
| Jury Demand | Defendant | Referred To | |
| Patents | 8,231,876; 8,420,081; 8,663,945; 8,715,664; 8,808,700; 8,883,156; 8,889,136; 8,895,009; 8,906,372; 8,906,373; 8,906,646; 8,911,964; 8,916,153; 8,926,975; 8,961,973; 8,961,974; 8,986,693; 8,999,337; 9,061,005; 9,062,106; 9,067,992; 9,085,618; 9,085,619; 9,085,620; 9,090,688; 9,090,689; 9,090,867; 9,096,666; 9,102,723; 9,150,645; 9,181,337; 9,181,572; 9,187,559; 9,234,032; 9,266,949; 9,273,132; 9,284,370; 9,284,371; 9,290,568; 9,315,574; 9,328,165; 9,334,319; 9,346,879; 9,359,434; 9,499,614; 9,499,616; 9,505,834; 9,512,216; 9,522,953; 9,550,826; 9,624,295; 9,669,093; 9,683,033; 9,708,400; 9,957,318 | ||
| Link to Docket | External link to docket | ||
Biologic Drugs cited in AbbVie Inc. v. Alvotech hf.
The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for AbbVie Inc. v. Alvotech hf. (N.D. Ill. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2021-12-21 | 130 | amended complaint | U.S. Patent No. 8,231,876 72. U.S. Patent No. 8,231,876 (the “’876 patent”), titled …will constitute infringement of U.S. Patent Nos. 6,805,686, 8,231,876, 8,420,081, 8,663,945, 8,708,968, … INFRINGEMENT OF U.S. PATENT NO. 8,231,876 224. AbbVie incorporates by …DECLARATORY JUDGMENT OF INFRINGEMENT OF U.S. PATENT NO. 8,231,876 237. AbbVie incorporates by … Protector Shroud 2. 8,231,876 Wan Purified Antibody | External link to document |
| 2022-02-21 | 247 | status report | deadlines for the Ten Patents are as follows: 1 U.S. Patent Nos. 6,805,686, 8,926,975, 8,961,973, 8,999,337…with respect to ten patents that will be subject to a first trial1 (“Ten Patents”). Dkt. 63 (2258); Dkt…the ’559 and ’216 patents based on the allegations previously pled for the ’973 patent. [AbbVie…Defenses of Inequitable Conduct, Unclean Hands, and Patent Misuse in 2258 (Dkt. 69 (2258)). On January…Defenses of Inequitable Conduct, Unclean Hands, and Patent Misuse in 2899 (Dkt. 214 (2899)). The Court has | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
